Francisco Gutierrez: Well, in our experience, I think that every patient or person that they offer this type of trial to should sign up or consider it. Because, well, it is not easy at first but there are many advantages at the end of treatment.

Matthew Lunning, M.D.: I believe that it is very important that we give individuals the opportunity to learn of clinical trials available to them, no matter what language they speak. In cases where English is not a patientŐs first language, we should let them know about 
equal-opportunity enrollment.

Maria Alvarran: Thank you so much to everybody. And to all those that have helped me, both ladies and young people. Thank you very much and may God give us more understanding.